New heart ablation technique aims to tame irregular heartbeats

NCT ID NCT07511166

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 4 times

Summary

This study tests a catheter-based procedure called Varipulse to treat paroxysmal atrial fibrillation (irregular heartbeat that comes and goes). Researchers want to see how well it works long-term when combined with different types of sedation. About 300 adults aged 18-80 with symptoms despite medication will be enrolled. The goal is to improve heart rhythm control and reduce the need for repeat procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Varipulse catheter ablation procedure
What this could lead to
If successful, this could improve the standard of care for atrial fibrillation ablation, leading to better long-term control of irregular heartbeats.
What could go wrong
This is an early-stage study with 300 participants, not yet recruiting. The procedure carries risks like bleeding, infection, or heart damage, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.